Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Ocular Very common (10% or more): Diabetic retinopathy (up to 20.1%) Common (1% to 10%): Retinal disorders, diabetic retinopathy complications Uncommon (0.1% to 1%): Nonproliferative retinopathy Very rare (less than 0.01%): Nonarteritic anterior ischemic optic neuropathy (NAION) Diabetic retinopathy complications included need for retinal photocoagulation, need for treatment with intravitreal agents, vitreous hemorrhage, and onset of diabetes-related blindness
(PubMed) Cavagnaro PF, Camargo A, Galmarini CR, Simon PW
New Drug Application 213051
Do Benefits Last After Stopping the Medication
What differs in practice is starting volume and titration speed, since women in these programs often start at a lower body weight and report more injection-site sensitivity at the top of the range
US$ 28.36
US$ 22.58
US$ 23.62
US$ 21.02
